Qiujin Shen

1.8k total citations
34 papers, 1.1k citations indexed

About

Qiujin Shen is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Qiujin Shen has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Qiujin Shen's work include Advanced Proteomics Techniques and Applications (3 papers), Blood properties and coagulation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Qiujin Shen is often cited by papers focused on Advanced Proteomics Techniques and Applications (3 papers), Blood properties and coagulation (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Qiujin Shen collaborates with scholars based in Sweden, China and United States. Qiujin Shen's co-authors include Masood Kamali‐Moghaddam, Wenxin Qin, Ulf Landegren, Lotta Wik, Måns Thulin, Jia Fan, Mats Nilsson, Xiaoyan Qian, Zhe Jin and Bryndis Birnir and has published in prestigious journals such as Nature Communications, Blood and Cancer.

In The Last Decade

Qiujin Shen

31 papers receiving 1.1k citations

Peers

Qiujin Shen
Comparison fields: 5 of 102
  • Molecular Biology 609
  • Cancer Research 258
  • Oncology 130
  • Immunology 117
  • Surgery 100
Replace Anatoly Samoylenko with:
Anatoly Samoylenko Finland
Limin Xu China
Lingling Liu China
Minghua Yu China
Amalia Luce Italy
Yu-Chuen Huang Taiwan
Judith Hagenbuchner Austria
Haiyan You China
Jianqiang Chen China
Ping Xu China
Anatoly Samoylenko Finland View profile →
Citations per field, relative to Qiujin Shen
Qiujin Shen · 1×
Citations per year, relative to Qiujin Shen
Qiujin Shen · 1×

Countries citing papers authored by Qiujin Shen

Since Specialization
Citations

This map shows the geographic impact of Qiujin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiujin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiujin Shen more than expected).

Fields of papers citing papers by Qiujin Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiujin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiujin Shen. The network helps show where Qiujin Shen may publish in the future.

Co-authorship network of co-authors of Qiujin Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Qiujin Shen. A scholar is included among the top collaborators of Qiujin Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiujin Shen. Qiujin Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 0
4 2
5 15
6 12
7 5
8 9
9 35
10 209
11 51
12 6
13 121
14 83
15 22
16 29
17 38
18 31
19 21
20 70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026